Skip to main content

Table 1 Baseline characteristics and intraoperative data of the patients

From: Effectiveness and safety of high-voltage pulsed radiofrequency to treat patients with primary trigeminal neuralgia: a multicenter, randomized, double-blind, controlled study

Variable

PRF group

(n = 67)

Nerve block group

(n = 67)

P value

Age (years)

58.24 ± 9.80

59.46 ± 11.69

0.203

Gender, male (%)

33 (49.3)

31(46.3)

0.729

Disease duration (months)

36 (24,45)

36 (24.5,60)

0.201

Laterality, right (%)

38 (56.7)

34 (50.7)

0.488

BNI score

 BNI IV

39 (58.2)

39 (58.2)

1.000

 BNI V

28 (41.8)

28 (41.8)

 

Dosage of Carbamazepine drugs (milligrams per day) Branch affected

500 (300–600)

500 (400–600)

0.194

V1, n (%)

1(1.5)

2 (3)

0.822

V2, n (%)

8(11.9)

7 (10.4)

 

V3, n (%)

11(16.4)

9 (13.4)

 

V1 + V2, n (%)

18(26.9)

13(19.4)

 

V2 + V3, n (%)

25(37.3)

30 (44.8)

 

V1 + V2 + V3, n (%)

4(6)

6(9)

 

PRF output voltage (v)

77 ± 11.9

  

2 Hz stimulating voltage (v)

0.1 (0.1,0.15)

0.1 (0.1,0.15)

0.758

50 Hz stimulating voltage(v)

0.1 (0.1,0.15)

0.1 (0.1,0.15)

0.481

Tissue resistance (Ω)

230 (219,244)

232 (219,249)

0.529

Surgery duration (min)

33 (32,36)

35(32,36)

0.342

  1. Values are expressed as the means ± standard deviation, median (IQR), counts or percentages
  2. BNI Counts or percentages, PRF Pulsed radiofrequency